Clinical Trials Directory

Trials / Completed

CompletedNCT02119702

Adolescent Master Protocol for Participants 18 Years of Age and Older (AMP Up)

Status
Completed
Phase
Study type
Observational
Enrollment
818 (actual)
Sponsor
Harvard School of Public Health (HSPH) · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This is a prospective cohort study designed to define the impact of HIV infection and antiretroviral therapy (ART) on young adults with perinatal HIV infection (YAPHIV) as they transition into adulthood. A group of of perinatally exposed but uninfected young adults from a similar sociodemographic background and age distribution will be enrolled for comparison.

Detailed description

AMP Up aims to define the impact of HIV infection and antiretroviral therapy (ART) on young adults with perinatal HIV infection as they transition into adulthood. A group of uninfected perinatally-exposed young adults from a similar sociodemographic background and age distribution will be enrolled for comparison. The primary objectives of this study are: * To identify infectious and non-infectious complications of HIV disease and toxicities resulting from long-term ART, including disease progression, immune dysfunction, viral resistance, end-organ disease, and mortality. * To define the impact of HIV infection and ART on the long-term clinical outcomes of young adults, including: * Metabolic abnormalities and risk factors for cardiovascular disease, including glucose and lipid metabolism, blood pressure, and body composition. * Sexually transmitted infections (Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, syphilis, human papillomavirus (HPV), genital warts and HSV) among males and females, and cervical HPV-associated pre-cancers and cancers and Mycoplasma genitalium and other vaginal microbiota among females. * Reproductive health, fertility, and pregnancy outcomes including mother-to-child transmission of HIV. * To define the impact of perinatal HIV infection, its concomitant risk factors and ART on long-term neurocognitive and behavioral health outcomes, including: * Mental health and neurocognitive functioning. * Health care behaviors, including adherence to ART, participation in health care services, and transition to adult clinical care. * Risk behaviors, including sexual behavior and substance use. * Independent living skills, and vocational and education achievement necessary for successful transition to adult functioning and quality of life.

Conditions

Timeline

Start date
2014-04-01
Primary completion
2025-05-31
Completion
2025-05-31
First posted
2014-04-22
Last updated
2025-06-27

Locations

14 sites across 2 countries: United States, Puerto Rico

Source: ClinicalTrials.gov record NCT02119702. Inclusion in this directory is not an endorsement.